Target Name: DAG1
NCBI ID: G1605
Other Name(s): beta-DG_(HUMAN) | Alpha-DG | Dystroglycan 1, transcript variant 1 | A3a | A-DG | dystroglycan 1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | Beta-dystroglycan | DAG | Dystroglycan 1, transcript variant 2 | Dystroglycan 1 preproprotein | Dystroglycan 1 | Dystrophin-associated glycoprotein-1 | DAG1 variant 1 | DAG1 variant 2 | AGRNR | 156DAG | MDDGA9 | MDDGC9 | Beta-DG | alpha-DG_(HUMAN) | beta-DG | LGMDR16 | MDDGC7 | Dystrophin-associated glycoprotein 1 | DAG1_HUMAN | Alpha-dystroglycan | Dystroglycan

DAG1: Drug and Radiation Detoxification, Cell Growth, Differentiation, Inflammation and Brain Barrier Regulation

DAG1 (beta-DG_(HUMAN)) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and heart. It is a key player in the detoxification of harmful substances and has been linked to a number of important cellular processes.

One of the most significant functions of DAG1 is its role in the detoxification of drugs, such as methamphetamine and polychlorinated biphenyls (PCBs). These substances are known to be toxic to the brain and have been linked to a number of serious health problems, including cancer, neurodegenerative diseases, and reproductive problems.

DAG1 is also involved in the detoxification of other harmful substances, including environmental toxins and industrial chemicals. It has been shown to be effective in reducing the levels of these substances in the body and may have potential as a drug target for treating a number of diseases.

In addition to its role in detoxification, DAG1 is also involved in a number of other important cellular processes. It is a signaling molecule that is involved in the regulation of cell growth, differentiation, and death. It is also involved in the production of reactive oxygen species (ROS), which can damage cells and contribute to a number of diseases.

DAG1 has also been shown to be involved in the regulation of inflammation. It is a source of reactive oxygen species (ROS) and has been shown to contribute to the production of ROS in the body. This may have implications for the development of inflammatory diseases.

DAG1 is also involved in the regulation of the blood-brain barrier. This barrier helps to protect the brain from harmful substances and is critical for the development and maintenance of brain health.

In conclusion, DAG1 (beta-DG_(HUMAN)) is a protein that is expressed in various tissues throughout the body and is involved in a number of important cellular processes. Its role in detoxification and inflammation may make it a potential drug target for the treatment of a number of diseases. Further research is needed to fully understand the functions of DAG1 and its potential as a drug.

Protein Name: Dystroglycan 1

Functions: The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization

More Common Targets

DAGLA | DAGLB | DALRD3 | DANCR | DAND5 | DANT2 | DAO | DAOA | DAOA-AS1 | DAP | DAP3 | DAPK1 | DAPK1-IT1 | DAPK2 | DAPK3 | DAPL1 | DAPP1 | DARS1 | DARS1-AS1 | DARS2 | DAW1 | DAXX | DAZ1 | DAZ2 | DAZ3 | DAZ4 | DAZAP1 | DAZAP2 | DAZAP2P1 | DAZL | DBET | DBF4 | DBF4B | DBF4P1 | DBH | DBH-AS1 | DBI | DBIL5P | DBIL5P2 | DBIP2 | DBIRD complex | DBN1 | DBNDD1 | DBNDD2 | DBNL | DBP | DBR1 | DBT | DBX1 | DBX2 | DCAF1 | DCAF10 | DCAF11 | DCAF12 | DCAF12L1 | DCAF12L2 | DCAF13 | DCAF13P3 | DCAF15 | DCAF16 | DCAF17 | DCAF4 | DCAF4L1 | DCAF4L2 | DCAF5 | DCAF6 | DCAF7 | DCAF8 | DCAF8L1 | DCAF8L2 | DCAKD | DCANP1 | DCBLD1 | DCBLD2 | DCC | DCD | DCDC1 | DCDC2 | DCDC2B | DCDC2C | DCHS1 | DCHS2 | DCK | DCLK1 | DCLK2 | DCLK3 | DCLRE1A | DCLRE1B | DCLRE1C | DCN | DCP1A | DCP1B | DCP2 | DCPS | DCST1 | DCST1-AS1 | DCST2 | DCSTAMP | DCT | DCTD